Synergism of polymyxin B (PMB), fosfomycin (FOF) and meropenem (MEM) in PMB-resistant Acinetobacter baumannii.
Evaluation of pharmacodynamics of MEM and FOF by Monte Carlo simulation.
Synergistic activity and reduction of MICs for MEM and FOF allows adequate PTA.
Proposal of therapeutic schemes for MEM and FOF alone and in combination.
Pharmacodynamic synergism can assist in treating multidrug-resistant A. baumannii.